Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
28m agoFrom Funan to the World Stage, Homegrown mc.2 Acquired by Global Leader Hunter Douglas After Two Decades of Consumer-Led Innovation
29m agoBOE, UNESCO introduce Asia-Pacific Science Club Network & 2026 Science Challenge
1h agoScorpio Tankers Inc. Prices Reopening of 1.75% Convertible Senior Notes due 2031 and Concurrent Stock Repurchase
3h agoAfya Limited Announces First-Quarter 2026 Financial Results
3h agoInnoCare Announces Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Sjögren's Syndrome in China
Volitionrx Limited logo

Volitionrx Limited

About

Volitionrx Limited — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 29 2026
Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing
Apr 23 2026
VolitionRx Announces Acceptance of Compliance Plan by NYSE American
Apr 20 2026
Volition Launches rNuQ™ Webshop Broadening Product Range
Mar 31 2026
VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in Belgium
Mar 30 2026
Volition Announces Mayo Clinic Study Demonstrates Nu.Q® Concentrations are Elevated in Trauma Patients

Community Chat

Ask AI

6ix6ixAIEvents